Polarographic behaviour of meloxicam and its determination in tablet preparations and spiked plasma.

Meloxicam is a new non-steroidal anti-inflammatory drug (NSAID), which has a higher activity cyclooxygenase-2 (COX-2) than against cyclooxygenase-1 (COX-1), with potentially high anti-inflammatory and analgesic action. The voltammetric behaviour of meloxicam was studied using direct current (DC), differential pulse polarography (DPP) and cyclic voltammetry (CV). The influence of several variables (including nature of the buffer, pH, concentration, modulation amplitude, scan rate, drop size, etc.) was examined in DPP method for meloxicam. The best DPP response was obtained in acetate buffer pH 4.88. The peak currents were measured with a static mercury drop electrode at -1.49 V versus Ag/AgCl. Calibration curve for meloxicam was linear at a concentration range from 0.38 to 15.0 microg ml(-1). The method was validated and applied to the determination of meloxicam in tablets, which were in two different dosage forms. A spectrophotometric method reported in the literature was utilized as a comparison method. There were no significant differences between the results obtained by two methods. DPP method is also available and applicable for the determination of mentioned substance in plasma. Mean recovery was 99.20+/-0.37%. It was concluded that the developed method was accurate, sensitive, precise, reproducible and useful for the quality control of meloxicam in pharmaceuticals and spiked plasma.

[1]  J. Joseph-Charles,et al.  Determination of meloxicam in tablet formulations by ultraviolet spectrophotometry and high-performance liquid chromatography , 1999 .

[2]  D. Türck,et al.  A review of the clinical pharmacokinetics of meloxicam. , 1996, British journal of rheumatology.

[3]  N. Özaltın Differential pulse polarographic determination of tenoxicam in pharmaceuticals and added to blood , 2000 .

[4]  G. Christian,et al.  Square Wave and Square Wave Adsorptive Stripping Voltammetric Comparison of the Anti-Inflammatory Drugs Piroxicam and Tenoxicam , 1990 .

[5]  L. Bebawy Stability-Indicating Method for the Determination of Meloxicam and Tetracaine Hydrochloride in the Presence of their Degradation Products , 1998 .

[6]  M. Ghoneim,et al.  Cathodic adsorptive stripping square-wave voltammetry of the anti-inflammatory drug meloxicam. , 2001, Chemical & pharmaceutical bulletin.

[7]  R. Bhardwaj,et al.  Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[8]  M. I. Albero,et al.  Spectrophotometric methods for determining meloxicam in pharmaceuticals using batch and flow-injection procedures. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  A. Bond Modern Polarographic Methods in Analytical Chemistry , 1980 .

[10]  F. Thaiss,et al.  Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis. , 1999, Kidney international.

[11]  F. Cerveró,et al.  Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: Central and peripheral components , 1997, Inflammation Research.

[12]  P. Luger,et al.  Structure and physicochemical properties of meloxicam, a new NSAID , 1996 .

[13]  H. Bird,et al.  An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment. , 1996, British journal of rheumatology.

[14]  J. Heyrovský Principles of polarography , 1966 .

[15]  G Altiokka,et al.  Pulse polarographic determination of meloxicam. , 2001, Die Pharmazie.

[16]  P. Zuman The Elucidation Of Organic Electrode Processes , 1969 .